These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19406245)

  • 1. Ectodomain orientation, conformational plasticity and oligomerization of ErbB1 receptors investigated by molecular dynamics.
    Kästner J; Loeffler HH; Roberts SK; Martin-Fernandez ML; Winn MD
    J Struct Biol; 2009 Aug; 167(2):117-28. PubMed ID: 19406245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain.
    Loeffler HH; Winn MD
    Proteins; 2013 Nov; 81(11):1931-43. PubMed ID: 23760854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion.
    Sanderson MP; Keller S; Alonso A; Riedle S; Dempsey PJ; Altevogt P
    J Cell Biochem; 2008 Apr; 103(6):1783-97. PubMed ID: 17910038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring higher-order EGFR oligomerisation and phosphorylation--a combined experimental and theoretical approach.
    Kozer N; Barua D; Orchard S; Nice EC; Burgess AW; Hlavacek WS; Clayton AH
    Mol Biosyst; 2013 Jul; 9(7):1849-63. PubMed ID: 23629589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.
    Zhang Z; Wriggers W
    Biochemistry; 2011 Mar; 50(12):2144-56. PubMed ID: 21275429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling.
    Pryor MM; Low-Nam ST; Halász AM; Lidke DS; Wilson BS; Edwards JS
    Biophys J; 2013 Sep; 105(6):1533-43. PubMed ID: 24048005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal growth factor receptor (HER1) aligned on the plasma membrane adopts key features of Drosophila EGFR asymmetry.
    Martin-Fernandez ML
    Biochem Soc Trans; 2012 Feb; 40(1):184-8. PubMed ID: 22260687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding.
    Low-Nam ST; Lidke KA; Cutler PJ; Roovers RC; van Bergen en Henegouwen PM; Wilson BS; Lidke DS
    Nat Struct Mol Biol; 2011 Oct; 18(11):1244-9. PubMed ID: 22020299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-cell structural dynamics of an EGF receptor during ligand-induced dimer-oligomer transition.
    Kozer N; Clayton AHA
    Eur Biophys J; 2020 Jan; 49(1):21-37. PubMed ID: 31740999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The architecture of EGFR's basal complexes reveals autoinhibition mechanisms in dimers and oligomers.
    Zanetti-Domingues LC; Korovesis D; Needham SR; Tynan CJ; Sagawa S; Roberts SK; Kuzmanic A; Ortiz-Zapater E; Jain P; Roovers RC; Lajevardipour A; van Bergen En Henegouwen PMP; Santis G; Clayton AHA; Clarke DT; Gervasio FL; Shan Y; Shaw DE; Rolfe DJ; Parker PJ; Martin-Fernandez ML
    Nat Commun; 2018 Oct; 9(1):4325. PubMed ID: 30337523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.
    Clayton AH; Walker F; Orchard SG; Henderson C; Fuchs D; Rothacker J; Nice EC; Burgess AW
    J Biol Chem; 2005 Aug; 280(34):30392-9. PubMed ID: 15994331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family.
    Arkhipov A; Shan Y; Kim ET; Dror RO; Shaw DE
    Elife; 2013 Jul; 2():e00708. PubMed ID: 23878723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR forms ligand-independent oligomers that are distinct from the active state.
    Byrne PO; Hristova K; Leahy DJ
    J Biol Chem; 2020 Sep; 295(38):13353-13362. PubMed ID: 32727847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK; Gilman M; Brugge JS
    Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coclustering of ErbB1 and ErbB2 revealed by FRET-sensitized acceptor bleaching.
    Szabó A; Szöllosi J; Nagy P
    Biophys J; 2010 Jul; 99(1):105-14. PubMed ID: 20655838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2014 Sep; 87():42-59. PubMed ID: 24928736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.